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Langmuir monolayersMyelin is the self-stacked membrane surrounding axons; it is also the target of several pathological and/or neu-
rodegenerative processes likemultiple sclerosis. These processes involve, among others, the hydrolytic attack by
phospholipases. In this work we describe the changes in isolated myelin structure after treatment with several
secreted PLA2 (sPLA2), by using small angle x-ray scattering (SAXS) measurements. It was observed that myelin
treated with all the tested sPLA2s (from cobra and bee venoms and from pig pancreas) preserved the lamellar
structure but displayed an enlarged separation between membranes in certain zones. Additionally, the peak
due to membrane asymmetry was clearly enhanced. The coherence length was also lower than the non-
treated myelin, indicating increased disorder. These SAXS results were complemented by Langmuir ﬁlm experi-
ments to followmyelinmonolayer hydrolysis at the air/water interface by a decrease in electric surface potential
at different surface pressures. All enzymes produced hydrolysis with nomajor qualitative difference between the
isoforms tested.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Myelin is the membrane wrapping axons allowing for saltatory
nerve conduction. It self-stacks in a unique way as a spiral structure.
Due to this fact, the myelin structures from CNS and from PNS are
among the best characterized natural membranes [1]. Myelin multi-
layers exhibit a rich phase behavior depending on the external condi-
tions [2–4]. This behavior follows similar trends in nerves and in
isolated membranes [5] as well as in monolayers at the air/water inter-
face [6]. This makes puriﬁed myelin a convenient membrane model in
order to study some processes of biological relevance, which otherwise
are difﬁcult to study in the nervous system in vivo.
Pathological, inﬂammatory and remodeling processes involve the
attack against myelin by several factors like cells [7], autoantibodies
[8], hydrolytic enzymes [7,9], among others. Secreted phospholipases
A2 (sPLA2) comprise a set of compact enzymes (13–15 kDa) showing
similarity in sequence and tertiary structure, requiring Ca2+ for hydro-
lytic activity [10]. These enzymes hydrolyze the sn-2 ester bond of sub-
strate glycerophospholipids, yielding a lysophospholipid and a fatty acidering; CNS, central nervous sys-
e; EAE, experimental autoim-
croscopy; LysoPC, 1-palmitoyl-
tory phospholipase A2; PNS,
ring.
.[10]. In myelin membranes the glycerophospholipids represent a total
mole fraction of ~0.3 [11].
There are proofs that different PLA2s (not restricted to sPLA2) act
during myelin-related neurological diseases like multiple sclerosis or
its laboratory model, the experimental autoimmune encephalomyelitis
(EAE) [12,13]. PLA2s affect myelin in other contexts, such as Wallerian
degeneration, the process of breakdown and phagocytosis of myelin
and axons distal to the site of a severe injury [14]. There is also current
interest in cases of less severe injury such as the effect of PLA2s against
myelin in post trauma events of the spinal cord [15,16]. Additionally,
virulence in speciﬁc strains causing amoebic (meningo) encephalitis
was correlated to myelin degradation by PLA2 secreted to the medium
by the microorganism [17,18].
Besides, lysophospholipids, one of the two products of the
PLA2−catalyzed hydrolysis, are used as inducers of demyelination
[19–22]. There still remains the question whether the role of lyso-
phospholipids is mainly lytic or through a metabolic effect as second
messengers [22].
Early biochemical work probed the activity of sPLA2 against isolated
myelin, showing that the main substrates are phosphatidylcholine,
phosphatidylethanolamine, and phosphatidylserine, and the hydrolytic
products remained associated to the membrane [23,24]. Additionally,
no structural alteration in myelin was observed by TEM [24]. However,
TEM induces artifacts and/or misinterpretations on myelin, as evi-
denced by studies of X-ray diffraction showing a series of alterations
in its packing and structure at the different stages of specimen prepara-
tion for TEM [25]; this remained as an open problem without general
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with TEM comes into question. On the other hand, coherent anti-
Stokes Raman scattering (CARS) microscopy showed that lyso-
phosphatidylcholine, as well as externally administered cytosolic
PLA2 induced the swelling of myelin [22].
In this work we characterized sPLA2-inducedmodiﬁcations onmye-
lin organization as assessed by small angle X-ray scattering (SAXS).
SAXS requires no further sample treatment after myelin isolation, and
(contrary to TEM) preserves the aqueous environment (water and sol-
utes) avoiding chemicalmodiﬁcation. It also collects data over relatively
big volumes, rendering a good statistical sampling. TEM, although visu-
ally rich, lacks all those beneﬁts.
Additionally, we performed experiments on Langmuir monolayers
of myelin at the air/water interface [6,27] to follow the sPLA2 catalyzed
hydrolysis by changes on electric surface potential [28,29].
2. Materials and methods
2.1. Chemicals
Highly puriﬁed myelin was prepared from bovine spinal cord
according to [30]. Brieﬂy, the puriﬁcation protocol consisted of sev-
eral osmotic shocks and direct as well as inverse sucrose gradient
centrifugations to discard graymatter constituents according to density.
After 3ﬁnal rinses in distilledwater themyelinmembraneswere lyoph-
ilized and stored at−20 or−70 °C. Chemicals were of analytical grade
and purchased from Merck (Germany). Myelin lipids were puriﬁed
according to [31].
L-DPPC and D-DPPC were from Avanti Polar Lipids (Alabama, USA),
sPLA2s from the venom of bee and Cobra (Naja naja) were from Sigma
Aldrich (USA), catalog numbers: P-6139, P-7778 respectively. sPLA2
from pig pancreas (Lecitase 10L) was from Novonordisk (Denmark).
2.2. Hydrolysis product quantitation
The quantitation of released free fatty acids after incubation of
myelin suspensions with sPLA2 was performed using an enzyme-
based colorimetric assay. For this, the HR Series NEFA-HR kit (Wako,
Japan) was used. Myelin was suspended at 6 μg/μL, in a solution of
145 mM NaCl, 10 mM HEPES, 2 mM CaCl2, pH = 7.4. sPLA2 was added
up to a concentration of 0.25 ng/μL (aprox. 17 nM) and 0.25 μg/μL
(17 μM) for total hydrolysis condition. After the time of incubation
with sPLA2 (1 h or 12 h for total hydrolysis), the kit reagents were
added following manufacturer's instructions. After this, the suspension
was centrifuged 5min at 12,000 ×g and the absorbance of the superna-
tant at 550 nm was quantiﬁed. Calibration curve was made using the
oleic acid solution provided in the kit. Controls included a no enzyme
tube, and a mixture of the full reaction mixture (including color
reagents) not subjected to incubation, in order to correct for non-
enzymatic color or dispersion.
2.3. Small-angle X-ray scattering (SAXS)
SAXS was measured to determine the regular spacings d between
bilayers ofmyelinmembrane suspensions, d= 2π/q, where q is the scat-
tering vector modulus q = 4πλ−1 ∗ (sin 2θ/2) and 2θ is the scattering
angle from the direct beam and λ is the X-ray wavelength. Measure-
ments were performed at the SAXS2 beamline at LNLS (Campinas,
Brazil). Lyophilized myelin was suspended at 6 mg/mL with a solution
of NaCl 145 mM, Hepes 10 mM, CaCl2 2 mM pH = 7.4, and homoge-
nized by extrusion (ﬁve times through a 26G needle ﬁtted to a syringe).
After this, the enzyme solution was added to a ﬁnal concentration of
0.25 ng/μL and incubated for 1 h at 37 °C unless otherwise stated.
Finally, the myelin suspension was ﬁlled into the sample holder be-
tween two mica plates for SAXS measurement. 1.488 Å radiation was
used and the sample detector distance was ~1 m. For radial integrationof the Debye–Scherrer rings on the 2D detector we employed the free
software Fit2D V12.077 from Andy Hammersley at European Synchro-
tron Radiation Facility. Coherence lengths were estimated from the
full width at half maximum of the major peak through the Scherrer
equation or by ﬁtting the data to a slabmodel. In some samples, sucrose
0.44 mM was added in order to avoid sample precipitation.
2.4. sPLA2-induced lipid and myelin monolayers hydrolysis followed by
surface potential
Lyophilized myelin was hydrated in water at 1 mg/mL. When about
to spread a monolayer at the air/water interface, 50 μL of that myelin
aqueous suspension was added to 950 μL of chloroform : methanol
2:1 and immediately spread onto the surface of the aqueous phase.
This was the same treatment given to a sPLA2 treated sample before
spreading. When using myelin lipids or DPPC, a chloroform–methanol
2:1 solution was prepared at 1 mg/mL and 0.5 mM respectively.
Hamilton syringes were used in all cases for spreading.
Subphase composition was the same as the solution used for the
suspension of myelin in the SAXS measurements, 145 mM NaCl,
10 mM Hepes, 2 mM CaCl2, pH = 7.4. It was checked for the absence
of surfactants by compression. Surface lateral pressure was followed
by the Wilhelmy plate method using a Monoﬁlmmeter built according
to [32] by Film Lift, Mayer Feintechnique, (Göttingen, Germany). The
surface potential was followed using a millivoltmeter with an air-
ionizing 241Am plate and Ag/AgCl electrode pair. Monolayer spreading
was done on a 16 cm2 trapezoidal trough with 18 mL, with constant
magnetic stirring, at 25 ± 0.5 °C. The target surface pressure was
reached at constant area by spreading up to the desired value. After
10 min of equilibration, enzyme injection was performed, up to a ﬁnal
concentration of 2 nM unless otherwise stated.
3. Results
3.1. Bulk whole myelin and sPLA2
Fig. 1 shows SAXS measurements performed at 37 °C on myelin be-
fore and after treatment with three different sPLA2s. Results are
expressed as I(q) (intensity) as a function of the scattering vector mod-
ulus q, (see point 2.3). Before the sPLA2 injection, (upper black curve) a
typical pattern for myelin, consisting of peaks around 0.8 and 1.6 nm−1
was observed. The ratio of positions of the diffraction peaks as whole
numbers (i. e. 1 : 2 : …) revealed a lamellar phase [33]. The black
curve indicates a major dominating lamellar phase with bilayers of
~7.85 nm periodicity [5,6]. After 1–2 h of incubation with sPLA2s, the
diffraction peaks split in two, with less sharp peaks at the original
value (q≈ 0.8 and 1.6 nm−1) and new peak positions (at q≈ 0.6 and
1.2 nm−1) also in 1:2 ratio. This showed an additional lamellar spacing
with a more expanded period, of around 10–11 nm. The enzymatic
activity did not destroy the original lamellar structure even after 24 h
incubation, but generated a partial change in its spacing. The analysis
(by using Scherrer equation) of the shape proﬁle of the native peak
(0.8 nm−1) rendered about 15 lamellar layers correlated before the
sPLA2 treatment (Fig. 1, inset); dropping to about half of that amount
after sPLA2 treatment.
Additional evidence of the persistence of lamellar structure/s was
the behavior of the I at lower q values (below the position of the diffrac-
tion peaks), following a power decay according to I ∝ q−2. This is evident
in the log–log graph of Fig. 2, where straight lines with different slopes
were drawn as references. The one in blue corresponds to I ∝ q−2. The
magenta line shows the constant value expected for globular micelles
as is the case of lyso-phosphatidyl choline (lyso-PC). Finally the gray
line shows the theoretical slope for the case of tubular micelles. Com-
plete analysis of the data at low q values (the so-called Guinier region)
is not possible in correlated systems such as myelin, which prevents
radius of gyration and molecular weight determinations, however
Fig. 1. Small angle X-ray diffraction of total myelin. Membranes before (upper black curve) and after exposure to sPLA2s from different origin (color curves); from top to bottom: cobra
venom (red), bee venom (green) and pig pancreas (blue) enzymes. Myelin showed the typical peak at qmax ~ 0.8 nm−1 (lamellar spacing of ~7.8 nm). A new expanded spacing was
shown by the new peak at ~0.6 nm−1(arrows). Inset, ﬁrst order diffraction peak of the untreated myelin sample (black curve in main ﬁgure) ﬁtted to a pseudo Voigt function, resulting
in a coherent length of themyelin lamellar stack of 120 nm,which is about 15 lamellae, that iswithin the values found for native and isolatedmyelin. After sPLA2 treatment, the coherence
length decayed at about a half of the original one. W represents the full width at half maximum used for calculation of the coherence length.
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tional to q−2 and this fact is maintained after hydrolysis suggesting at
least a not detectable change in the dimensionality (2D) of the lamellar
arrangement.
Another new feature evident after sPLA2 treatment is the appear-
ance or enhancement of the peak located at ~0.4 nm−1. This is exactly
at half the value of the native, normal strong peak at 0.8 nm−1, and cor-
responds to a duplication of the unit cell of the remaining native period,
from 7.85 nm to 15.7 nm. Therefore, the enzymatic activity led to an in-
creased asymmetry with a unit cell consisting of two bilayers, whichFig. 2. Double logarithmic representation of SAXS data. Low q region is explored in the
double logarithmic representation of the data (see text). Curves: non-treated myelin
(black), sPLA2-treated myelin as shown in Fig. 1 (red) and LysoPC (green). Both myelin
curves match their slopes at low q with the blue reference line I ∝ q−2 (lamellar), while
LysoPC, one product of the hydrolytic reaction, shows a relationship I ∝ q0 (a limiting con-
stant value) as the magenta line (globular micelles). The gray line with I ∝ q−1 for tubular
micelles does not match any set of data. The data at low q (q b 0.3–0.4 nm−1) suggested
that myelin membranes persisted after hydrolytic attack.could be related to the fact that exposed phospholipids were preferen-
tially degraded (see below).
3.2. Hydrolysis product assay in myelin
After 1 h incubation at 37 °C, the pig pancreas sPLA2 hydrolyzed 10
to 15% (0.04–0.06 μmol permgmyelin) of the totalmyelin hydrolyzable
phospholipids whereas the cobra venom enzyme hydrolyzed 35 to 45%.
The total hydrolyzable phospholipid was deﬁned as the amount of
quantitated fatty acid after 12 h incubation with sPLA2 at 17 μM
(1000-fold enzyme increase). These last facts are in agreement with
previous results [23,24]. The free fatty acids before incubation with
17 nM sPLA2were below technique's sensitivity, however, after 12 h in-
cubation the non-sPLA2 added control sample showed detectable fatty
acid production.
3.3. Bulk myelin lipid extract and sPLA2
The puriﬁed myelin lipid extract in the presence of 2 mM CaCl2
(needed for sPLA2 catalyzed hydrolysis) showed a certain proportion
of correlated lamellae as detected by clear Bragg peaks (Fig. 3, black
curve). Under sPLA2 hydrolysis these peaks shifted to lower q (Fig. 3,
red curve), showing an analogous effect in the same direction as for
whole myelin (Fig. 1). Nevertheless, the shift was reduced in compari-
son to whole myelin. The inset in Fig. 3 shows analogous behavior to
whole myelin with I(q) slopes proportional to q−2, evidencing the
lamellar arrangement even after PLA2 treatment.
3.4. sPLA2-induced hydrolysis in Langmuir monolayers
To follow hydrolysis of myelin monolayers we turned to the contin-
uousmeasurement of surface electric potential. As controls, we checked
the action of sPLA2 on L-DPPC monolayers and observed a drop in sur-
face potential, as reported in earlier work [28]. This drop was absent
in D-DPPC (non-hydrolysable enantiomer) monolayers after sPLA2 in-
jection, showing the enantiomeric selectivity of the enzyme and the
Fig. 3. Small angle x-ray diffraction of myelin lipids. Myelin lipids shifted to larger spacings (lower q, red curve, brown arrow) under sPLA2 action. The inset shows a log–log representation
of the data with lines of I ∝ q−2 (lamellar, green), I ∝ q−1 (tubular, blue) and I ∝ q−0 (globular micelles, cyan). The data at low q (q b 0.3) indicates that myelin lipid membranes persisted
after hydrolytic attack, as observed for whole myelin.
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the racemic (1:1) mixture the drop was proportional to the amount of
L-DPPC.
Using the same technique we injected sPLA2 from pig pancreas and
cobra venom below myelin monolayers. The surface potential dropped
very reproducibly and the rate of decay was inversely related to the
original surface pressure (Fig. 4A).
This, together with the quantiﬁcation of released free fatty acids of
the bulk condition is an indication of the partial hydrolysis of phospho-
lipids and the suitability of the surface potential (ΔV) to follow enzyme
kinetics. Higher lateral surface pressure extended the ΔV equilibration
time. At 19 mN·m−1 the equilibrium was reached in 10 min, but at
38 mN·m−1 the equilibrium was reached in about 1 h (Fig. 4A). This
is the normal trend found for sPLA2s. The surface pressure showed a
less obvious and retarded decrease making it impractical to follow as a
reaction indicator. This suggests that the products of hydrolysis were
still remaining in the monolayer in good proportion, analogous to the
case of bulk myelin membranes in our and other's works [23].
In other experiments we incubated myelin in bulk with sPLA2
before monolayer spreading. Then, after formation of monolayer of
that sPLA2-treated myelin and subsequent enzyme injection, the drop
in surface potential was around 40% of the drop seen when the myelin
was not pre-treated with sPLA2 (Fig. 4B). This would reﬂect the preser-
vation of somephospholipids not accessible to the enzymeuntil spread-
ing, as suggested by the increased asymmetry in SAXS results. When a
lipid extract from myelin was spread as monolayer (Fig. 5), the surface
potential drop upon hydrolysis was greater than whole myelin (Fig. 4),
and the cobra venom sPLA2 (Fig. 5A) was clearly more active than the
pancreatic one (Fig. 5B). This was also the case with whole extracted
myelin andwas in accordance to the bulk assay quantitation of released
fatty acids (data not shown).
4. Discussion
4.1. Whole myelin
The experimental decays of intensity at q values below the ﬁrst
diffraction peaks (q b 0.3–0.6 nm−1) matched the one corresponding
to a planar (lamellar) structure. If micelles appeared after hydrolysis,(as is normally the case for pure fatty acids, as well as pure lyso-
phospholipids) a plateau in I(q) would be expected for these structures
and consequently a decay in the slope at low q values, which was not
the case. This fact supports the idea that the hydrolytic products
remained in the membrane, which agrees with the original determina-
tions based in centrifugation experiments [23,24]. Then we agree with
the seminal work in that the membrane planar structure is maintained
after sPLA2 digestion. But we disagreewith the previously reported lack
of effect on myelin lamellae packing [24].
The novelty in this work is to show a deﬁned, partial separation in
quantitative terms (of about 1.5–2.5 nm) between correlated myelin
lamellae after sPLA2 treatment, and that this did not occur over the
entiremembrane surface. This was accompanied by an increased asym-
metry deduced by the appearance of the peak at 0.4 nm−1 (period
duplication). We speculate that this separation should be more
pronounced in the extracellular side of isolated myelin. The peak at
0.4 nm−1 is evident in nerve myelin but tends to be lower or absent
after isolation [5], getting stronger whenever there is a splitting of the
major peak at 0.8 nm−1 by any given circumstance [4,6].
The three sPLA2s we tested displayed the same effect on myelin,
leading to a new expanded period that could have physio-pathological
relevance since it disturbs the packing status of myelin. Adhesion
between myelin layers plays an important role on myelin stability and
opposes the characteristic demyelination of several myelin altered
states. Demyelination is preceded by loss ofmembrane adhesion, swell-
ing, vesiculation, and ﬁnally myelin disintegration [8,19]; clearly PLA2s
could be responsible for some of the ﬁrst steps.
In the past it was postulated that even if sPLA2s chemically degraded
myelin, this would not affect the ultrastructure as seen by TEM [24].
Only when sPLA2 addition was combined with protease (trypsin), a
membrane decoupling was observed by TEM [24]. In this regard it was
also shown by low-angle X-ray diffraction that the action of proteases
(trypsin and Pronase, separately) induce remodeling in myelin [34],
although with some discrepancies [24,35]. The observation that sPLA2
does not alter the myelin packing is quite surprising if we take into
account that one of the hydrolytic products (lysophospholipid) is used
to induce demyelination from long time ago and it was observed an
extensive myelin reorganization after its intraneural injection [19,20].
Lysophospholipids are still extensively employed as a model to study
Fig. 4. Surface potential in whole myelin monolayers after sPLA2 injection. (A) Effect of
injection (t = 0 s) of cobra venom sPLA2 (2 nM) on the surface potential difference
(ΔΔV) changes at different initial surface pressure. At higher surface pressure (Πi =
38 mN·m−1), the drop rate was reduced (red curve). (B) The drop was lower (~50%) in
myelin pre-treated with sPLA2 before spreading, showing the partial digestion of the
membranes, measurements at 19 mN·m−1.
Fig. 5. Surface potential difference in myelin lipids monolayers after sPLA2 injection. The
surface potential drop (ΔΔV) appeared as a general phenomenon. In fact, in this case
the surface potential drop is even greater than in whole myelin. (A) 15 nM cobra venom
sPLA2 (B) 15 nM sPLA2 from pig pancreas, produced a less pronounced ΔΔV drop rate,
and a notably slower drop at 35 mN·m−1 (red line).
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We speculate that a possible reason for the discrepancy could be the
fact that it was shown that TEM specimen preparation leads to artifacts
with shrinking of the physiological states ofmyelin as assessed by X-ray
diffraction [25]. Even in early times it was accepted that shrinking is a
common phenomenon in myelin TEM preparations [36]. This artifact
is absent in X-ray observations. Shrinking could compensate or obscure
the expansion of the membranes in the particular conditions on which
PLA2 is assayed.More recently, it was demonstrated an increased swell-
ing and disorder of myelin induced by PLA2s and lysophospholipids
by using CARS microscopy [22]. In this work we showed evidence
of the structural change induced by different sPLA2s by using SAXS
and following Debye–Scherrer rings shifts and changes in peak
proﬁle related to coherence length by the Scherrer equation. The
decrease in coherence length is indicative of fewer correlated mem-
branes and thus of increased disorder. The spacing appeared to be
bimodal, part retained the physiological value but other part was
expanded by about 2 nm. Additionally, there was an increment in
the asymmetry of the native period, as detected by the appearance
of a discernible peak at 0.4 nm−1. This peak marks the natural
asymmetry of the native membrane, but is more difﬁcult to observein isolated CNS myelin [5,37]. In our case this increment was proba-
bly linked to the changes in composition [38]. Similar period duplica-
tion has been observed in simpler systems consisting of dipalmitoyl-
phosphatidylcholine (DPPC) mixed with its hydrolysis products [38]
and reﬂects the asymmetry of the bilayer. In myelin this could be due
to increased asymmetry between the exposed and hydrolyzed
(outer) monolayer and the non-exposed (inner) monolayer of the
membrane bilayer. So far, no general rule can be extracted about
the response of myelin to enzymes regarding the change in symme-
try; for instance exposition to proteases decreases the PNS myelin
asymmetry [34] which is the opposite to the results with sPLA2.
We speculate that the decoupling of membranes in whole myelin
can be due to increased LysoPC and/or increment of negative surface
charge density due to fatty acids generation. The shift of the peak and
the decoupling was weaker in isolated lipids as compared to whole
myelin, but it happened over the entire sample. It should be taken
into account thatmost probably the shift on lipidswas not so noticeable
because there was already (prior to sPLA2 hydrolysis) a big amount
(around 10 mol%) of anionic lipids [11] and because the new generated
charge density can dilute over all the lipidic membrane.
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Electrostatic surface potential differences (ΔΔV) is a provedmethod
to follow the hydrolysis in Langmuir monolayers [28,29,39]. After
enzyme injection below myelin monolayers at the air/water interface,
ΔΔV were very similar for both paradigmatic enzymes, the one from
pig pancreas, and from cobra venom, after 1 h incubation. Cobra
venom sPLA2 displayed consistently greater rates ofΔΔV drop at all sur-
face pressures. However, we concluded that after enough time (1 h to
2 h incubation, depending on the initial surface pressure), both enzymes
induced equal ΔΔV value.
In order to help to rationalize our observations in whole myelin, we
performed the same study on two simpler substrates. One, a puriﬁed
myelin lipids extract (no protein) and two, pure single lipids (L-DPPC
and D-DPPC) and its racemic mixture. Puriﬁed myelin lipids showed
also a drop in surface potential (Fig. 5) as did L-DPPC, but not D-DPPC
(Fig S1). It should be taken into account that the binding afﬁnity of
sPLA2s for theD-enantiomermonolayer equals that of the L phospholip-
id [40]. From analysis of the racemic mixture it was evident that depo-
larization was proportional to the density of substrate. Therefore, ΔΔV
could be used as a measure of the phospholipid hydrolysis in these sim-
pler systems.
In our SAXS determinations we did not follow the continuous pro-
cess of the myelin modiﬁcation, rather its initial and ﬁnal states (the
new expanded and more asymmetric state of myelin) which produced
the same SAXS spectra for all the three tested enzymes. Nevertheless,
it is known that the different sPLA2s assayed could have different
kinetics and efﬁciency in the hydrolytic process. These possible differ-
ences were analyzed here in Langmuir monolayer experiments. These
secreted enzymes generally display great activity [41] at the physiolog-
ical pH of the extracellular side of the CNS, which is around 7.4 [42].
Different sPLA2s have different preference for substrates, but they
also differ on the lateral molecular packing (followed by surface pres-
sureΠ) atwhich they are able to efﬁciently hydrolyze pure phospholip-
id Langmuir monolayers at the air/water interface. For instance, pig
pancreas (digestive) sPLA2 shows a markedly lower value of lateral
pressure for pure short chain PCsﬁlms atwhich the optimumhydrolysis
of monolayers is attained when compared with both, bee venom and
cobra venom sPLA2, having an almost null activity at 20 mN·m−1 [43,
44]. Although cobra venom sPLA2 still produced a faster hydrolysis at
all pressures at the same bulk concentration, the difference with the
pancreatic enzyme was not as sharp as reported for pure PC. Consis-
tently, pancreatic sPLA2 also hydrolyzedmyelin bilayers that, according
to our previouswork have highmolecular lateral packing, equivalent to
the one near the monolayer collapse [6,45].4.3. PLA2 and myelin damage/remodeling
PLA2s are known to be key participants in demyelination processes
[7], like multiple sclerosis or its laboratory model, the EAE [12,13].
Additionally, it is well known that macrophages (and other cells) are
commonly located at places of myelin injury and these cells are able
to secrete PLA2s [46] which are often associated to inﬂammatory
processes. In all the general histo-morphological routes toward demye-
lination (stripping, dying back, vesiculation, phagocytosis [47]) the
destabilization of the apposition between the membranes appears to
be an early requisite.
PLA2s affect myelin also in Wallerian degeneration [14] and in
cases of less severe injury such as post trauma events of the spinal
cord [15,16]. In other scenarios, like amoebic (meningo) encephalitis
infection, PLA2 appear to be a determinant factor, as virulence is
linked to PLA2 activity in secreted medium [18]. In fact, demyelin-
ation by Naegleria fowleri proceeds via phospholipolytic attack as
the main factor [17]. Additionally, lysophospholipid, are used as in-
ducers of demyelination [19–22].In our work we clearly showed that PLA2s (beyond its probed
capability to chemically degrade myelin molecular constituents)
are able to induce an increased and deﬁned separation betweenmyelin
membranes, which could represent one of the ﬁrst steps on myelin
destabilization, turning it more accessible to other (bio)chemical
agents.
5. Conclusion
We examined myelin periodicity incubated with different secreted
phospholipases A2 by employing SAXS. As a result, myelin qualitatively
preserved its lamellar structure, part of myelin kept the normal period-
icity but other part expanded, with only a fraction of phospholipids
being actually degraded. Even the paradigmatic non-venom pancreatic
phospholipase attackedmyelin. This serves as an indication that is likely
that even not very potent phospholipases could produce structural
changes if acting on myelin, loosening its packing.
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